Skip to search formSkip to main contentSkip to account menu

BMS224818

Known as: BMS 224818, BMS-224818 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

abataceptbelatacept

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
FDA Pipeline Preview, June 2010 (BMS-224818, Roflumilast, Prostvac, Naltrexone, IL13-PE38QQR/IL13-PE, Prochymal, AEZS-108, SBC-102, Pralatrexate, RG2833)
Recent FDA action (through, May 2010) related to BMS-224818, Roflumilast, Prostvac, Naltrexone, IL13-PE38QQR/IL13-PE, Prochymal… 
Review
2001
Review
2001
The role of newer monoclonal antibodies in renal transplantation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)